{
  "main_header": {
    "sid": 546345,
    "name": "Morepen Labs.",
    "stock_name": "Morepen Labs.",
    "full_name": "Morepen Laboratories Ltd",
    "name_url": "stocks-analysis/morepen-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "51.02",
    "chg": -0.5,
    "chgp": "-0.97%",
    "dir": -1,
    "prev_price": "51.52",
    "mcapval": "2,850.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500288,
    "symbol": "MOREPENLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE083A01026",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "63.64 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/morepen-labs-546345-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-27 15:15:22",
        "description": "Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26  Business Standard..."
      }
    ],
    "total": 1,
    "sid": "546345",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/morepen-laboratories-546345"
  },
  "announcements": [
    {
      "caption": "Reply To Clarification On Price Movement",
      "datetime": "10-Jun-2026",
      "details": "Please find enclosed the reply",
      "source": "BSE"
    },
    {
      "caption": "Clarification sought from Morepen Laboratories Ltd",
      "datetime": "10-Jun-2026",
      "details": "The Exchange has sought clarification from Morepen Laboratories Ltd on June 10 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-May-2026",
      "details": "Newspaper Publication- Q4 and FY 26 Financial Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Morepen Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Aug 25",
          "dt": "2025-08-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26

2026-05-27 15:15:22

Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26 Business Standard...

Read More

View All News